Bank Of America Corp Evolus, Inc. Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Evolus, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 70,853 shares of EOLS stock, worth $1.16 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
70,853
Previous 93,504
24.22%
Holding current value
$1.16 Million
Previous $1.31 Million
41.33%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding EOLS
# of Institutions
163Shares Held
49.1MCall Options Held
453KPut Options Held
14K-
Perceptive Advisors LLC New York, NY5.75MShares$94.6 Million1.81% of portfolio
-
Tang Capital Management LLC San Diego, CA4.85MShares$79.7 Million6.42% of portfolio
-
Black Rock Inc. New York, NY4.01MShares$65.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.99MShares$49.1 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.91MShares$47.9 Million2.11% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $922M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...